When given as an intraperitoneal injection or a nasal dose, it protected mice from SARS-CoV-2 illness, as measured by maintenance of body weight and clearance of virus from mouse lungs four days after infection, said the team from University of Alabama at Birmingham. "New Covid variants pose risk of evading the immune system "even in vaccinated infected individuals" said James J Kobie, from the varsity.from International-News-Economic Times https://ift.tt/pvaZ8bo
0 comments:
Post a Comment